Status:
COMPLETED
Neural Therapy in Notalgia Paresthetica
Lead Sponsor:
Sisli Hamidiye Etfal Training and Research Hospital
Conditions:
Notalgia Paresthetica
Eligibility:
All Genders
30-60 years
Brief Summary
Patients diagnosed with Notalgia paresthetica and who received neural therapy within the last year were retrospectively screened. In the evaluations before treatment and at the 3rd month after treatme...
Eligibility Criteria
Inclusion
- the presence of a hyperpigmented skin lesion consistent with NP
- minimum 6 months for duration of disease
- 30-60 aged
- application of neural therapy in a manner appropriate to the diagnosis
Exclusion
- history of previous surgery or injection in the thoracic region
- presence of another treatment in the same period
- presence of any cardiac or pulmonary disease, malignancy, or advanced psychiatric disease
Key Trial Info
Start Date :
June 26 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 10 2024
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT06508073
Start Date
June 26 2024
End Date
July 10 2024
Last Update
July 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital
Istanbul, Turkey (Türkiye)